FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3147702902> ?p ?o ?g. }

• W3147702902 endingPage "100061" @default.
• W3147702902 startingPage "100061" @default.
• W3147702902 abstract "Control of the trypanosomosis has been targeted towards vector control or by the use of antitrypanosomal drugs such as diminazene aceturate and isometamidium with reports of toxicity and relapse following treatment. Hence, the need for continuous research for a safe, efficacious and less toxic drug. In previous studies, artemisinin has shown antitrypanosomal effects against Trypanosoma brucei rhodesiense and also against Trypanosoma brucei brucei (T. b. brucei) in vitro. This period of drug repurposing has led to scientists searching for ways of utilising artemisinin because of its reported multifunctionality and ability to mediate several targets that are important for different diseases. To evaluate the in vivo effects of artemisinin against T. b. brucei following the in vitro assay. Previously to perform the in vivo assays, the in vitro effects of artemisinin on the T. b. brucei trypomastigotes growth were assessed. The in vivo effects were tested on Wistar rats at doses 5 mg/kg and 10 mg/kg, respectively. All Wistar rats were euthanised at the end of the experiment; kidney, lung, liver and brain samples were harvested and processed for histopathological examination. Complete cessation (p < 0.001) of trypanosomal motility in vitro by 2 and 20 µg/µl artemisinin between 10 to 60 min was observed when compared to the controls. Artemisinin showed an IC50 value of 0.42 µg/µl while the positive control drug diminazene aceturate displayed a lower activity with IC50 of 2.99 µg/µl. Level of parasitaemia and survival rate showed significant differences (p < 0.05) in treated groups compared to group II (Infected and untreated). Mean packed cell volume, haemoglobin concentration, mean corpuscular volume and mean corpuscular haemoglobin concentration decreased significantly (p < 0.05) in all infected groups and returned to almost pre-infection values following treatment. Histopathological evaluation showed artemisinin to prevent the distortion of normal architecture of the selected organs. In vitro, artemisinin produced a complete inhibition of T. b. brucei motility at 2 and 20 µg/µl. In vivo, artemisinin at 5 and 10 mg/kg prevented histoarchitecture damage of selected organs and caused an elevated haematological profile." @default.
• W3147702902 created "2021-04-13" @default.
• W3147702902 creator A5025095786 @default.
• W3147702902 creator A5025308423 @default.
• W3147702902 creator A5042724939 @default.
• W3147702902 creator A5050279509 @default.
• W3147702902 creator A5055817016 @default.
• W3147702902 creator A5087081863 @default.
• W3147702902 creator A5088112258 @default.
• W3147702902 date "2021-08-01" @default.
• W3147702902 modified "2023-10-16" @default.
• W3147702902 title "In vitro assay and in vivo effect of artemisinin in Trypanosoma brucei brucei-infected Wistar rats" @default.
• W3147702902 cites W1970144610 @default.
• W3147702902 cites W2005525640 @default.
• W3147702902 cites W2080913045 @default.
• W3147702902 cites W2112722298 @default.
• W3147702902 cites W2121285877 @default.
• W3147702902 cites W2128408768 @default.
• W3147702902 cites W2160728506 @default.
• W3147702902 cites W2161715647 @default.
• W3147702902 cites W2161979413 @default.
• W3147702902 cites W2163143519 @default.
• W3147702902 cites W2415187468 @default.
• W3147702902 cites W2469563904 @default.
• W3147702902 cites W2589285117 @default.
• W3147702902 cites W2753689973 @default.
• W3147702902 cites W2790492537 @default.
• W3147702902 cites W2807178059 @default.
• W3147702902 cites W2891501243 @default.
• W3147702902 cites W2891754777 @default.
• W3147702902 cites W2891925093 @default.
• W3147702902 cites W2912077025 @default.
• W3147702902 cites W2997898742 @default.
• W3147702902 cites W3138356114 @default.
• W3147702902 cites W4244358260 @default.
• W3147702902 doi "https://doi.org/10.1016/j.phyplu.2021.100061" @default.
• W3147702902 hasPublicationYear "2021" @default.
• W3147702902 type Work @default.
• W3147702902 sameAs 3147702902 @default.
• W3147702902 citedByCount "0" @default.
• W3147702902 crossrefType "journal-article" @default.
• W3147702902 hasAuthorship W3147702902A5025095786 @default.
• W3147702902 hasAuthorship W3147702902A5025308423 @default.
• W3147702902 hasAuthorship W3147702902A5042724939 @default.
• W3147702902 hasAuthorship W3147702902A5050279509 @default.
• W3147702902 hasAuthorship W3147702902A5055817016 @default.
• W3147702902 hasAuthorship W3147702902A5087081863 @default.
• W3147702902 hasAuthorship W3147702902A5088112258 @default.
• W3147702902 hasBestOaLocation W31477029021 @default.
• W3147702902 hasConcept C104317684 @default.
• W3147702902 hasConcept C150903083 @default.
• W3147702902 hasConcept C159047783 @default.
• W3147702902 hasConcept C202751555 @default.
• W3147702902 hasConcept C203014093 @default.
• W3147702902 hasConcept C207001950 @default.
• W3147702902 hasConcept C2775867548 @default.
• W3147702902 hasConcept C2776120307 @default.
• W3147702902 hasConcept C2777459041 @default.
• W3147702902 hasConcept C2777752497 @default.
• W3147702902 hasConcept C2778048844 @default.
• W3147702902 hasConcept C2778143080 @default.
• W3147702902 hasConcept C2778371730 @default.
• W3147702902 hasConcept C2779502636 @default.
• W3147702902 hasConcept C2780035454 @default.
• W3147702902 hasConcept C2909346784 @default.
• W3147702902 hasConcept C55493867 @default.
• W3147702902 hasConcept C86803240 @default.
• W3147702902 hasConcept C98274493 @default.
• W3147702902 hasConceptScore W3147702902C104317684 @default.
• W3147702902 hasConceptScore W3147702902C150903083 @default.
• W3147702902 hasConceptScore W3147702902C159047783 @default.
• W3147702902 hasConceptScore W3147702902C202751555 @default.
• W3147702902 hasConceptScore W3147702902C203014093 @default.
• W3147702902 hasConceptScore W3147702902C207001950 @default.
• W3147702902 hasConceptScore W3147702902C2775867548 @default.
• W3147702902 hasConceptScore W3147702902C2776120307 @default.
• W3147702902 hasConceptScore W3147702902C2777459041 @default.
• W3147702902 hasConceptScore W3147702902C2777752497 @default.
• W3147702902 hasConceptScore W3147702902C2778048844 @default.
• W3147702902 hasConceptScore W3147702902C2778143080 @default.
• W3147702902 hasConceptScore W3147702902C2778371730 @default.
• W3147702902 hasConceptScore W3147702902C2779502636 @default.
• W3147702902 hasConceptScore W3147702902C2780035454 @default.
• W3147702902 hasConceptScore W3147702902C2909346784 @default.
• W3147702902 hasConceptScore W3147702902C55493867 @default.
• W3147702902 hasConceptScore W3147702902C86803240 @default.
• W3147702902 hasConceptScore W3147702902C98274493 @default.
• W3147702902 hasIssue "3" @default.
• W3147702902 hasLocation W31477029021 @default.
• W3147702902 hasLocation W31477029022 @default.
• W3147702902 hasOpenAccess W3147702902 @default.
• W3147702902 hasPrimaryLocation W31477029021 @default.
• W3147702902 hasRelatedWork W1999550448 @default.
• W3147702902 hasRelatedWork W2169991195 @default.
• W3147702902 hasRelatedWork W2296125709 @default.
• W3147702902 hasRelatedWork W2323035093 @default.
• W3147702902 hasRelatedWork W2418607650 @default.
• W3147702902 hasRelatedWork W2904092203 @default.

• next